The move comes after early-stage trial failed to result in a clear signal it slowed the disease process.
Source link
Biogen and Ionis Pharma shares slide as they end development of ALS treatment
The move comes after early-stage trial failed to result in a clear signal it slowed the disease process.
Source link
